For instance, gemtuzumab ozogamicin, which targets CD33 in acute myeloid leukemia, frequently causes ALT/AST elevations, despite CD33 being absent in hepatic tissue [20]. The gene discussed is CD33; the disease is acute myeloid leukemia.